Literature DB >> 22898358

An exploratory, randomized, crossover MRI study of microbicide delivery with the SILCS diaphragm compared to a vaginal applicator.

Sara Pentlicky1, Mark Rosen, Patricia S Coffey, M Kilbourne-Brook, A Shaunik, Courtney A Schreiber, Kurt Barnhart.   

Abstract

BACKGROUND: Microbicide gels studied for HIV prevention often are delivered via a single-use vaginal applicator. Using a contraceptive diaphragm such as the SILCS diaphragm for gel delivery could have advantages, including lower cost and additional pregnancy prevention. STUDY
DESIGN: We performed an exploratory, nonblinded, randomized, crossover study among healthy, sexually active, nonpregnant women. Using BufferGel, we evaluated three microbicide delivery methods for gel distribution and retention: SILCS single-sided gel delivery, SILCS double-sided gel delivery and a vaginal applicator (without SILCS). Magnetic resonance images were taken at baseline, after gel insertion, and immediately and 6 h after simulated intercourse. Three women completed all gel delivery methods described in this article.
RESULTS: Magnetic resonance imaging analysis indicated similar gel spread in the vagina among all three methods. SILCS single-sided gel application resulted in the most consistent longitudinal coverage; SILCS double-sided gel application was the most consistent in the transverse dimension.
CONCLUSIONS: Gel coverage was similar with all three methods. These results suggest that the SILCS microbicide delivery system is comparable to vaginal applicators for delivery of gel products intravaginally.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22898358      PMCID: PMC3580797          DOI: 10.1016/j.contraception.2012.06.016

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  15 in total

Review 1.  Improving topical microbicide applicators for use in resource-poor settings.

Authors:  Janet G Vail; Jessica A Cohen; Kimberly L Kelly
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

2.  Distribution of a 3.5-mL (1.0%) C31G vaginal gel using magnetic resonance imaging.

Authors:  Kurt T Barnhart; E Scott Pretorius; Kelly Timbers; David Shera; Mayadah Shabbout; Daniel Malamud
Journal:  Contraception       Date:  2005-05       Impact factor: 3.375

3.  Microbicide applicators: understanding design preferences among women in the dominican republic and South Africa.

Authors:  Jessica A Cohen; Matthew S Steele; Francisco I Cáceres Ureña; Mags E Beksinska
Journal:  Sex Transm Dis       Date:  2007-01       Impact factor: 2.830

4.  Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States.

Authors:  K H Mayer; J Peipert; T Fleming; A Fullem; T Moench; S Cu-Uvin; M Bentley; M Chesney; Z Rosenberg
Journal:  Clin Infect Dis       Date:  2001-01-26       Impact factor: 9.079

5.  Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial.

Authors:  Kurt T Barnhart; Michael J Rosenberg; H Trent MacKay; Diana L Blithe; Jim Higgins; Terri Walsh; Livia Wan; Michael Thomas; Mitchell D Creinin; Carolyn Westhoff; William Schlaff; David F Archer; Charletta Ayers; Andrew Kaunitz; Sutapa Das; Thomas R Moench
Journal:  Obstet Gynecol       Date:  2007-09       Impact factor: 7.661

6.  SILCS diaphragm: postcoital testing of a new single-size contraceptive device.

Authors:  Jill L Schwartz; Susan A Ballagh; Mitchell D Creinin; Robert W Rountree; Maggie Kilbourne-Brook; Christine K Mauck; Marianne M Callahan
Journal:  Contraception       Date:  2008-07-03       Impact factor: 3.375

7.  Magnetic resonance imaging to determine the distribution of a vaginal gel: before, during, and after both simulated and real intercourse.

Authors:  E Scott Pretorius; Kelly Timbers; Dan Malamud; Kurt Barnhart
Journal:  Contraception       Date:  2002-12       Impact factor: 3.375

8.  Baseline dimensions of the human vagina.

Authors:  Kurt T Barnhart; Adriana Izquierdo; E Scott Pretorius; David M Shera; Mayadah Shabbout; Alka Shaunik
Journal:  Hum Reprod       Date:  2006-02-14       Impact factor: 6.918

9.  Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY jelly used with a diaphragm.

Authors:  D'Nyce L Williams; Daniel R Newman; Susan A Ballagh; Mitchell D Creinin; Kurt Barnhart; Debra H Weiner; April J Bell; Denise J Jamieson
Journal:  Sex Transm Dis       Date:  2007-12       Impact factor: 2.830

10.  In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse.

Authors:  Kurt Thomas Barnhart; E Scott Pretorius; Kelly Timbers; David Shera; Mayadah Shabbout; Daniel Malamud
Journal:  Contraception       Date:  2004-12       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.